NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-036-2007-0-US-02 Cloning And Characterization Of Calcitonin Gene Related Peptide Receptors US ORD 10/440,479 Abandoned
NIAID E-031-2004-1-US-01 Anti-Tubercular Drug: Compositions And Methods US CIP 10/440,017 Abandoned
NCI E-247-2003-0-US-01 Vanilloid Receptor Antagonists, and Methods of Making and Using Them US 60/471,210 Abandoned
NCI E-017-2002-0-EP-03 SCYTOVIRINS AND RELATED CONJUGATES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOST CELLS, COMPOSITIONS, ANTIODIES, AND METHODS OF USING SCYTOVIRINS EP National Stage 03753112.6 Abandoned
NCI E-017-2002-0-AU-04 SCYTOVIRINS AND RELATED CONJUGATES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOST CELLS, COMPOSITIONS, ANTIODIES, AND METHODS OF USING SCYTOVIRINS AU National Stage 2003248545 Abandoned
NCI E-017-2002-0-PCT-02 SCYTOVIRINS AND RELATED CONJUGATES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOST CELLS, COMPOSITIONS, ANTIODIES, AND METHODS OF USING SCYTOVIRINS PCT PCT PCT/US03/15991 Expired
NIAID E-090-1996-0-US-05 CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION [Aron Diamond Cell Line] US CON 10/439,845 Abandoned
NCI E-113-1991-0-US-03 RAF PROTEIN KINASE THERAPEUTICS US CON 10/440,341 Abandoned
NIA E-216-2002-0-US-01 GIP (1-30) GLUd3 as a Treatment for Type II Diabetes US 60/471,368 Abandoned
NCI E-017-2002-0-CA-05 SCYTOVIRINS AND RELATED CONJUGATES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOST CELLS, COMPOSITIONS, ANTIODIES, AND METHODS OF USING SCYTOVIRINS CA National Stage 2484719 Abandoned
NHGRI E-004-2002-0-PCT-02 USE OF HOMO SAPIENS CHROMOSOME 1 OPEN READING FRAME 28 (C1ORF28) IN THE DIAGNOSIS OF HYPERPARATHYROIDISM-JAW TUMOR SYNDROME (HPT-JT) PCT PCT PCT/US03/15081 Abandoned
NIA E-176-2002-0-US-02 DNA Modifying Molecules and Methods of Use Thereof US ORD 10/438,076 Abandoned
NCI E-026-2001-0-US-04 Cosalane Compounds and Methods for their Use US DIV 10/436,845 Abandoned
NCI E-301-2002-0-US-01 Cyclooxygenase Inhibition with Nitroxyl US 60/470,320 Abandoned
NCI E-253-2003-0-US-01 Cytotoxic Indeno- And Isoindoloisoquinoline US 60/469,718 Abandoned
NIAID E-031-2004-2-EA-10 Anti-Tubercular Drug: Compositions And Methods EA National Stage 200401522 Expired
NCI E-038-2003-0-PCT-01 Gamma Beta-Mediated Recombination At The Replication Fork With Synthetic Single Strand DNA Oliganucleotides. Generation Of Mismatched DNA Strands: A Model. PCT PCT PCT/US2003/14657 Expired
NIMH E-044-1997-0-US-08 NOVEL IMMUNOTOXINS AND METHODS OF INDUCING IMMUNE TOLERANCE US DIV 10/435,567 Abandoned
NIDDK E-165-1999-0-US-03 Potentiation of Antineoplastic Agents Using Sigma-2 Ligands US National Stage 10/275,830 Abandoned
NCI E-038-2003-1-US-01 Host Cells Deficient for Mismatch Repair and Their Use in Methods for Inducing Homologous Recombination Using Single-Stranded Nucleic Acids US 60/469,494 Abandoned
NCI E-165-1995-1-US-13 DEPIGMENTING ACTIVITY OF AGOUTI SIGNAL PROTEIN AND PEPTIDES THEREOF US CON 10/435,238 Abandoned
NCI E-189-2002-0-PCT-02 POLYDIAZENIUMDIALATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND METHODS OF USING SAME. PCT PCT PCT/US2003/014180 Expired
NCI E-189-2002-0-EP-03 POLYDIAZENIUMDIALATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND METHODS OF USING SAME. EP National Stage 03728738.0 Abandoned
NCI E-189-2002-0-CA-04 POLYDIAZENIUMDIALATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND METHODS OF USING SAME. CA National Stage 2485167 Abandoned
NCI E-144-2002-1-CA-06 Identification of Novel Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies CA National Stage 2485120 Abandoned
NCI E-144-2002-1-AU-05 Identification of Novel Broadly Cross-Reactive Neutralizing Human Monoclonal Antibodies AU National Stage 2003239356 Abandoned
NCI E-144-2002-0-AU-05 IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES AU National Stage 2003237187 Abandoned
NCI E-144-2002-1-PCT-02 Identification of Novel Broadly Cross-Reactive Neutralizing Human Monoclonal Antibodies PCT PCT PCT/US2003/014095 Expired
NCI E-144-2002-0-PCT-02 IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES PCT PCT PCT/US2003/014292 Expired
NCI E-144-2002-0-EP-04 IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES EP National Stage 03736557.4 Abandoned
NCI E-144-2002-1-EP-04 Identification of Novel Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies EP National Stage 03733940.5 Abandoned
NIDDK E-146-2002-0-US-01 Methods and Compositions to Detect Microbes In Fecal Samplesc US 60/468,341 Abandoned
NIDCR E-331-2002-0-US-01 Activation of Recombinant Diphtheria Toxin Fusion Proteins By Specific Proteases Highly Expressed on the Surface of Tumor Cells US 60/468,577 Abandoned
NCI E-144-2002-0-CA-06 IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES CA National Stage 2484930 Abandoned
NHGRI E-167-2001-1-US-06 Methods and Compostiiions for the Repair and/or Regeneration of Damaged Myocardium US CON 10/430,100 Abandoned
NIBIB E-143-2000-0-US-03 Sample Delivery System With Laminar Mixing for Microvolume Biosensing US National Stage 10/415,909 Abandoned
NHLBI E-325-2001-2-US-02 Production of Adeno-Associated Virus In Insect Cells US National Stage 10/415,834 7271002 Expired PDF
NCI E-182-2002-0-PCT-02 Immunotherapy Regimens in HIV-Infected Patients PCT PCT PCT/US2003/013737 Expired
NCI E-052-2002-0-PCT-02 TUMOR SUPPRESSOR GENE POLYPEPTIDES AND RELATED NUCLEIC ACIDS, HOST CELLS, COMPOSITIONS, AND METHODS OF USE IN INHIBITION OF CELL GROWTH.. PCT PCT PCT/US2003/013287 Expired
NIAID E-001-1996-0-US-06 NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS US CON 10/425,855 7488477 Expired PDF
NHLBI E-190-2003-0-US-01 Biological Activities Of Protein Arginine N-methyltransferase 2 (PRMT2)
Title as filed: Protein Arginine N-methyltransferase 2 (PRMT-2) 		US 60/466,751 Abandoned
NCI E-175-2003-0-US-01 Eosinophil-Derived Neurotoxin Induces Dentritic Cell Maturation US 60/466,797 Abandoned
NCI E-166-2003-0-US-01 Nanoparticular Tumor Targeting And Therapy US 60/466,375 Abandoned
NCI E-191-2003-0-US-01 Eosinophil-derived neurotoxin is immunostimulant US 60/466,796 Abandoned
NCI E-014-2000-0-US-02 Secreted Frizzled Related Protein Fragments US DIV 10/425,586 7223853 Expired PDF
NCI E-308-2000-0-US-07 Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same US National Stage 10/415,431 Abandoned
NCI E-253-2002-0-US-01 Compositions and Methods for Detecting Abnormal Cell Proliferation (Semaphorin Application) US 60/466,154 Abandoned
NCI E-209-2003-0-US-01 High Throughput Screening for Cancer Genes US 60/466,089 Abandoned
NIAID E-089-2002-1-BR-05 Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 BR National Stage PI0309631-9 Expired
NIAID E-089-2002-1-AT-54 Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 AT EP 10177735.7 Expired